BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 20234369)

  • 1. Circulating microRNAs in plasma of patients with gastric cancers.
    Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
    Komatsu S; Ichikawa D; Tsujiura M; Konishi H; Takeshita H; Nagata H; Kawaguchi T; Hirajima S; Arita T; Shiozaki A; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Anticancer Res; 2013 Jan; 33(1):271-6. PubMed ID: 23267156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
    Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
    Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.
    Cui L; Zhang X; Ye G; Zheng T; Song H; Deng H; Xiao B; Xia T; Yu X; Le Y; Guo J
    Cancer; 2013 May; 119(9):1618-26. PubMed ID: 23335180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
    BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
    Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
    PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
    Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
    Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
    Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
    J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
    Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
    Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
    Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
    Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
    Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
    Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
    Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
    Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
    Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.